Covid-19 roundup: Po­lit­i­cal pres­sures at FDA con­tin­ue post-elec­tion; Med­ica­go takes GSK ad­ju­vant in­to its first PhII/III

Though the pres­i­den­tial elec­tion has come and gone, ten­sions be­tween the White House and gov­ern­ment health of­fi­cials re­main.

With the news out Mon­day that Pfiz­er and BioN­Tech’s Covid-19 vac­cine has proven more than 90% ef­fec­tive in the first in­ter­im analy­sis, Pres­i­dent Trump lashed out at HHS Sec­re­tary Alex Azar and FDA chief Stephen Hahn over the re­sults com­ing six days af­ter Elec­tion Day, per the Wash­ing­ton Post. Trump told Azar to “get to the bot­tom” of what hap­pened, re­port­ed­ly claim­ing with­out ev­i­dence Pfiz­er de­lib­er­ate­ly with­held the analy­sis to sab­o­tage his re-elec­tion chances.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER